Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute …
KA Krychtiuk, I Ahrens, H Drexel… - … Heart Journal: Acute …, 2022 - academic.oup.com
After experiencing an acute coronary syndrome (ACS), patients are at a high risk of suffering
from recurrent ischaemic cardiovascular events, especially in the very early phase. Low …
from recurrent ischaemic cardiovascular events, especially in the very early phase. Low …
Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)
KC Koskinas, S Windecker, G Pedrazzini… - Journal of the American …, 2019 - jacc.org
Background: Although guidelines recommend in-hospital initiation of high-intensity statin
therapy in patients with acute coronary syndromes (ACS), low-density lipoprotein cholesterol …
therapy in patients with acute coronary syndromes (ACS), low-density lipoprotein cholesterol …
Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve …
Primary percutaneous coronary intervention is nowadays the preferred reperfusion strategy
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
for patients with acute ST-segment–elevation myocardial infarction, aiming at restoring …
“No-reflow” phenomenon: a contemporary review
Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …
patients with STEMI according to current international guidelines of the European Society of …
Brazilian Society of cardiology guidelines on unstable angina and acute myocardial infarction without ST-segment elevation–2021
SciELO - Brasil - Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e
Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021 Diretrizes da …
Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021 Diretrizes da …
[HTML][HTML] Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
Coronary no-reflow (CNR) is a frequent phenomenon that develops in patients with ST-
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
segment elevation myocardial infarction (STEMI) following reperfusion therapy. CNR is …
[HTML][HTML] Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled …
CM Gibson, JJP Kastelein, AT Phillips, PE Aylward… - American heart …, 2021 - Elsevier
Acute myocardial infarction (MI) patients remain at high risk for recurrent events. Cholesterol
efflux, mediated by apolipoprotein AI, removes excess cholesterol from atherosclerotic …
efflux, mediated by apolipoprotein AI, removes excess cholesterol from atherosclerotic …
Platelet‐to‐lymphocyte ratio and prognosis in STEMI: a meta‐analysis
G Dong, A Huang, L Liu - European Journal of Clinical …, 2021 - Wiley Online Library
Background Platelet‐to‐lymphocyte ratio (PLR) is a haematological index which reflects
increased level of inflammation and thrombosis. We aimed to summarize the potential …
increased level of inflammation and thrombosis. We aimed to summarize the potential …
A narrative review of statin-induced rhabdomyolysis: molecular mechanism, risk factors, and management
N Safitri, MF Alaina, DAE Pitaloka… - Drug, healthcare and …, 2021 - Taylor & Francis
Although statins are effective for treating hypercholesterolemia, they can have various side
effects, including rhabdomyolysis, a potentially fatal condition. This review evaluated the …
effects, including rhabdomyolysis, a potentially fatal condition. This review evaluated the …